Galinpepimut-S

· Sellas Life Sciences Group

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Galinpepimut-S, covering 2024-10-09 to 2025-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2 [Phase 3]